ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 77.67% of ELYM shares are held by financial institutions. RA CAPITAL MANAGEMENT, L.P. is the top corporate investor, holding 13.15M shares valued at $36.03M. A 47.48% stake in Eliem Therapeutics, Inc. is owned by the company. MORGAN STANLEY owns 1.71K shares valued at $4.68K, which translates its holding of 0.01% of the stake in the company.
Among the ELYM insiders holding of 10.38% of the stake in company, AI ETI LLC, 10 percent owner, holds the largest shares of 5.01M. RA CAPITAL MANAGEMENT, L.P., , is the second largest ELYM insider with ownership of 2.87M shares. MORISSET VALERIE, EVP, R&D AND CSO, stands third with possession of 31.32K shares of that stake.